Jiménez R, Constantinescu A, Yazir M, Alfonso-Triguero P, Pequerul R, Parés X, Pérez-Alea M, Candiota AP, Farrés J, Lorenzo J. Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in Glioblastoma. Int J Mol Sci. 2024 Oct 26;25(21):11512. doi: 10.3390/ijms252111512. PMID: 39519068; PMCID: PMC11546810.
Ungan G, Pons-Escoda A, Ulinic D, Arús C, Ortega-Martorell S, Olier I, Vellido A, Majós C, Julià-Sapé M. Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous. NMR Biomed. 2024 Apr;37(4):e5095. doi: 10.1002/nbm.5095. Epub 2024 Jan 11. PMID: 38213096.
Wu Y, Lloveras V, Lope-Piedrafita S, Mulero-Acevedo M, Candiota AP, Vidal-Gancedo J. Synthesis and Relaxivity Study of Amino Acid-Branched Radical Dendrimers as MRI Contrast Agents for Potential Brain Tumor Imaging. Acta Biomater. 2024 Dec 6:S1742-7061(24)00715-3. doi: 10.1016/j.actbio.2024.12.006. Epub ahead of print. PMID: 39647652.
